Showing 11-20 of 10000 results for ""
Protected: DRAFT Sanofi
There is no excerpt because this is a protected post.
Protected: DRAFT Patient Education Resources
There is no excerpt because this is a protected post.
Balancing Mental Health and Type 1 Diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and taking your insulin.
C-peptide: Everything You Need to Know
It was identified in the late 1960s. Since then, studies have shown that it is a biomarker for beta cell function. In other words, it’s a measure of beta cell health and insulin production. If it’s low (or you have none), it indicates that your pancreas is producing little or no insulin. There was even […]
Emilia Roche
Breakthrough T1D Walk, Lakeland, FL
Kendal Webb
Breakthrough T1D Walk, Charlottesville, VA
Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
NEW YORK, April 22, 2026—Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today’s decision by the U.S. Food and Drug Administration (FDA) to approve Sanofi’s Tzield (teplizumab-mzwv) for use in children ages one and older to delay the onset of insulin-dependent T1D. Tzield, the world’s first disease-modifying […]
Tzield Approved for Children Ages One and Older in Stage 2 T1D
What’s happening? The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. This is a huge win for the T1D community! Breakthrough T1D applauds the FDA for this approval and Sanofi for their commitment to new therapies for the T1D […]
FY27 Walk Nuclavis Mobile Messaging
Jellico Test Location, GA
WalkBreakthrough T1D Walk, Lehigh Valley, PA
Goodman Stadium, Bethlehem, PA
Walk
